ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immuno-oncology Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-9Y14138
Home | Market Reports | Health| Pharmacy
Global Immuno oncology Therapy Market Insights Forecast to 2029
BUY CHAPTERS

Global Immuno-oncology Therapy Market Research Report 2025

Code: QYRE-Auto-9Y14138
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Astrazeneca plc
Bristol–Myers Squibb
Eli Lilly
Roche
GlaxoSmithKline PLC
Janssen Biotech
Merck
Novartis
Pfizer Inc
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics

Immuno-oncology Therapy Market Size

The global market for Immuno-oncology Therapy was valued at US$ 1317 million in the year 2024 and is projected to reach a revised size of US$ 1785 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Immuno-oncology Therapy Market

Immuno-oncology Therapy Market

Immuno-oncology therapy is a type of cancer treatment that harnesses the body"s immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The market for immuno-oncology therapy is driven by the growing interest in personalized and targeted cancer treatments and the need for innovative therapies with fewer side effects. The market"s growth is also influenced by the approval of new immuno-oncology drugs and ongoing research in cancer immunotherapy.
This report aims to provide a comprehensive presentation of the global market for Immuno-oncology Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-oncology Therapy.
The Immuno-oncology Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immuno-oncology Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-oncology Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Immuno-oncology Therapy Market Report

Report Metric Details
Report Name Immuno-oncology Therapy Market
Accounted market size in year US$ 1317 million
Forecasted market size in 2031 US$ 1785 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck, Novartis, Pfizer, Sanofi, Spectrum Pharmaceuticals, Takeda, BioNTech SE, Allogene Therapeutics, IMAB-I-Mab Biopharma Co., Ltd., Arcus Biosciences, Gritstone Oncology, Autolus Therapeutics, Rubius Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Immuno-oncology Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Immuno-oncology Therapy Market growing?

Ans: The Immuno-oncology Therapy Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Immuno-oncology Therapy Market size in 2031?

Ans: The Immuno-oncology Therapy Market size in 2031 will be US$ 1785 million.

Who are the main players in the Immuno-oncology Therapy Market report?

Ans: The main players in the Immuno-oncology Therapy Market are Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck, Novartis, Pfizer, Sanofi, Spectrum Pharmaceuticals, Takeda, BioNTech SE, Allogene Therapeutics, IMAB-I-Mab Biopharma Co., Ltd., Arcus Biosciences, Gritstone Oncology, Autolus Therapeutics, Rubius Therapeutics

What are the Application segmentation covered in the Immuno-oncology Therapy Market report?

Ans: The Applications covered in the Immuno-oncology Therapy Market report are Hospitals, Ambulatory Surgical Center, Others

What are the Type segmentation covered in the Immuno-oncology Therapy Market report?

Ans: The Types covered in the Immuno-oncology Therapy Market report are Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines

Recommended Reports

Cancer Therapies

Immunotherapy Markets

Cellular Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Immuno-oncology Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-oncology Therapy Market Perspective (2020-2031)
2.2 Global Immuno-oncology Therapy Growth Trends by Region
2.2.1 Global Immuno-oncology Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immuno-oncology Therapy Historic Market Size by Region (2020-2025)
2.2.3 Immuno-oncology Therapy Forecasted Market Size by Region (2026-2031)
2.3 Immuno-oncology Therapy Market Dynamics
2.3.1 Immuno-oncology Therapy Industry Trends
2.3.2 Immuno-oncology Therapy Market Drivers
2.3.3 Immuno-oncology Therapy Market Challenges
2.3.4 Immuno-oncology Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-oncology Therapy Players by Revenue
3.1.1 Global Top Immuno-oncology Therapy Players by Revenue (2020-2025)
3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immuno-oncology Therapy Revenue
3.4 Global Immuno-oncology Therapy Market Concentration Ratio
3.4.1 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Therapy Revenue in 2024
3.5 Global Key Players of Immuno-oncology Therapy Head office and Area Served
3.6 Global Key Players of Immuno-oncology Therapy, Product and Application
3.7 Global Key Players of Immuno-oncology Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-oncology Therapy Breakdown Data by Type
4.1 Global Immuno-oncology Therapy Historic Market Size by Type (2020-2025)
4.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2026-2031)
5 Immuno-oncology Therapy Breakdown Data by Application
5.1 Global Immuno-oncology Therapy Historic Market Size by Application (2020-2025)
5.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immuno-oncology Therapy Market Size (2020-2031)
6.2 North America Immuno-oncology Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immuno-oncology Therapy Market Size by Country (2020-2025)
6.4 North America Immuno-oncology Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-oncology Therapy Market Size (2020-2031)
7.2 Europe Immuno-oncology Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immuno-oncology Therapy Market Size by Country (2020-2025)
7.4 Europe Immuno-oncology Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-oncology Therapy Market Size (2020-2031)
8.2 Asia-Pacific Immuno-oncology Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-oncology Therapy Market Size (2020-2031)
9.2 Latin America Immuno-oncology Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immuno-oncology Therapy Market Size by Country (2020-2025)
9.4 Latin America Immuno-oncology Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-oncology Therapy Market Size (2020-2031)
10.2 Middle East & Africa Immuno-oncology Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-oncology Therapy Introduction
11.1.4 Amgen Revenue in Immuno-oncology Therapy Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-oncology Therapy Introduction
11.2.4 AstraZeneca Revenue in Immuno-oncology Therapy Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-oncology Therapy Introduction
11.4.4 Eli-Lilly Revenue in Immuno-oncology Therapy Business (2020-2025)
11.4.5 Eli-Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-oncology Therapy Introduction
11.5.4 Roche Revenue in Immuno-oncology Therapy Business (2020-2025)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-oncology Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2020-2025)
11.6.5 GlaxoSmithKline Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-oncology Therapy Introduction
11.7.4 Janssen Biotech Revenue in Immuno-oncology Therapy Business (2020-2025)
11.7.5 Janssen Biotech Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-oncology Therapy Introduction
11.8.4 Merck Revenue in Immuno-oncology Therapy Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-oncology Therapy Introduction
11.9.4 Novartis Revenue in Immuno-oncology Therapy Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-oncology Therapy Introduction
11.10.4 Pfizer Revenue in Immuno-oncology Therapy Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-oncology Therapy Introduction
11.11.4 Sanofi Revenue in Immuno-oncology Therapy Business (2020-2025)
11.11.5 Sanofi Recent Development
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Details
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2020-2025)
11.12.5 Spectrum Pharmaceuticals Recent Development
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-oncology Therapy Introduction
11.13.4 Takeda Revenue in Immuno-oncology Therapy Business (2020-2025)
11.13.5 Takeda Recent Development
11.14 BioNTech SE
11.14.1 BioNTech SE Company Details
11.14.2 BioNTech SE Business Overview
11.14.3 BioNTech SE Immuno-oncology Therapy Introduction
11.14.4 BioNTech SE Revenue in Immuno-oncology Therapy Business (2020-2025)
11.14.5 BioNTech SE Recent Development
11.15 Allogene Therapeutics
11.15.1 Allogene Therapeutics Company Details
11.15.2 Allogene Therapeutics Business Overview
11.15.3 Allogene Therapeutics Immuno-oncology Therapy Introduction
11.15.4 Allogene Therapeutics Revenue in Immuno-oncology Therapy Business (2020-2025)
11.15.5 Allogene Therapeutics Recent Development
11.16 IMAB-I-Mab Biopharma Co., Ltd.
11.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Details
11.16.2 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
11.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Introduction
11.16.4 IMAB-I-Mab Biopharma Co., Ltd. Revenue in Immuno-oncology Therapy Business (2020-2025)
11.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Development
11.17 Arcus Biosciences
11.17.1 Arcus Biosciences Company Details
11.17.2 Arcus Biosciences Business Overview
11.17.3 Arcus Biosciences Immuno-oncology Therapy Introduction
11.17.4 Arcus Biosciences Revenue in Immuno-oncology Therapy Business (2020-2025)
11.17.5 Arcus Biosciences Recent Development
11.18 Gritstone Oncology
11.18.1 Gritstone Oncology Company Details
11.18.2 Gritstone Oncology Business Overview
11.18.3 Gritstone Oncology Immuno-oncology Therapy Introduction
11.18.4 Gritstone Oncology Revenue in Immuno-oncology Therapy Business (2020-2025)
11.18.5 Gritstone Oncology Recent Development
11.19 Autolus Therapeutics
11.19.1 Autolus Therapeutics Company Details
11.19.2 Autolus Therapeutics Business Overview
11.19.3 Autolus Therapeutics Immuno-oncology Therapy Introduction
11.19.4 Autolus Therapeutics Revenue in Immuno-oncology Therapy Business (2020-2025)
11.19.5 Autolus Therapeutics Recent Development
11.20 Rubius Therapeutics
11.20.1 Rubius Therapeutics Company Details
11.20.2 Rubius Therapeutics Business Overview
11.20.3 Rubius Therapeutics Immuno-oncology Therapy Introduction
11.20.4 Rubius Therapeutics Revenue in Immuno-oncology Therapy Business (2020-2025)
11.20.5 Rubius Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Amgen Inc
Astrazeneca plc
Bristol–Myers Squibb
Eli Lilly
Roche
GlaxoSmithKline PLC
Janssen Biotech
Merck
Novartis
Pfizer Inc
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
List of Tables
 Table 1. Global Immuno-oncology Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Immune Checkpoint Inhibitors
 Table 4. Key Players of Immune System Modulators
 Table 5. Key Players of Cancer Vaccines
 Table 6. Global Immuno-oncology Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Immuno-oncology Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Immuno-oncology Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Immuno-oncology Therapy Market Share by Region (2020-2025)
 Table 10. Global Immuno-oncology Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Immuno-oncology Therapy Market Share by Region (2026-2031)
 Table 12. Immuno-oncology Therapy Market Trends
 Table 13. Immuno-oncology Therapy Market Drivers
 Table 14. Immuno-oncology Therapy Market Challenges
 Table 15. Immuno-oncology Therapy Market Restraints
 Table 16. Global Immuno-oncology Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Immuno-oncology Therapy Market Share by Players (2020-2025)
 Table 18. Global Top Immuno-oncology Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2024)
 Table 19. Ranking of Global Top Immuno-oncology Therapy Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Immuno-oncology Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Immuno-oncology Therapy, Headquarters and Area Served
 Table 22. Global Key Players of Immuno-oncology Therapy, Product and Application
 Table 23. Global Key Players of Immuno-oncology Therapy, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Immuno-oncology Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Immuno-oncology Therapy Revenue Market Share by Type (2020-2025)
 Table 27. Global Immuno-oncology Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Immuno-oncology Therapy Revenue Market Share by Type (2026-2031)
 Table 29. Global Immuno-oncology Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Immuno-oncology Therapy Revenue Market Share by Application (2020-2025)
 Table 31. Global Immuno-oncology Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Immuno-oncology Therapy Revenue Market Share by Application (2026-2031)
 Table 33. North America Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Immuno-oncology Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Immuno-oncology Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Immuno-oncology Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Immuno-oncology Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Immuno-oncology Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Immuno-oncology Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Immuno-oncology Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Immuno-oncology Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Immuno-oncology Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Immuno-oncology Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Amgen Company Details
 Table 49. Amgen Business Overview
 Table 50. Amgen Immuno-oncology Therapy Product
 Table 51. Amgen Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 52. Amgen Recent Development
 Table 53. AstraZeneca Company Details
 Table 54. AstraZeneca Business Overview
 Table 55. AstraZeneca Immuno-oncology Therapy Product
 Table 56. AstraZeneca Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 57. AstraZeneca Recent Development
 Table 58. Bristol-Myers Squibb Company Details
 Table 59. Bristol-Myers Squibb Business Overview
 Table 60. Bristol-Myers Squibb Immuno-oncology Therapy Product
 Table 61. Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 62. Bristol-Myers Squibb Recent Development
 Table 63. Eli-Lilly Company Details
 Table 64. Eli-Lilly Business Overview
 Table 65. Eli-Lilly Immuno-oncology Therapy Product
 Table 66. Eli-Lilly Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 67. Eli-Lilly Recent Development
 Table 68. Roche Company Details
 Table 69. Roche Business Overview
 Table 70. Roche Immuno-oncology Therapy Product
 Table 71. Roche Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 72. Roche Recent Development
 Table 73. GlaxoSmithKline Company Details
 Table 74. GlaxoSmithKline Business Overview
 Table 75. GlaxoSmithKline Immuno-oncology Therapy Product
 Table 76. GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 77. GlaxoSmithKline Recent Development
 Table 78. Janssen Biotech Company Details
 Table 79. Janssen Biotech Business Overview
 Table 80. Janssen Biotech Immuno-oncology Therapy Product
 Table 81. Janssen Biotech Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 82. Janssen Biotech Recent Development
 Table 83. Merck Company Details
 Table 84. Merck Business Overview
 Table 85. Merck Immuno-oncology Therapy Product
 Table 86. Merck Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 87. Merck Recent Development
 Table 88. Novartis Company Details
 Table 89. Novartis Business Overview
 Table 90. Novartis Immuno-oncology Therapy Product
 Table 91. Novartis Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 92. Novartis Recent Development
 Table 93. Pfizer Company Details
 Table 94. Pfizer Business Overview
 Table 95. Pfizer Immuno-oncology Therapy Product
 Table 96. Pfizer Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 97. Pfizer Recent Development
 Table 98. Sanofi Company Details
 Table 99. Sanofi Business Overview
 Table 100. Sanofi Immuno-oncology Therapy Product
 Table 101. Sanofi Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 102. Sanofi Recent Development
 Table 103. Spectrum Pharmaceuticals Company Details
 Table 104. Spectrum Pharmaceuticals Business Overview
 Table 105. Spectrum Pharmaceuticals Immuno-oncology Therapy Product
 Table 106. Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 107. Spectrum Pharmaceuticals Recent Development
 Table 108. Takeda Company Details
 Table 109. Takeda Business Overview
 Table 110. Takeda Immuno-oncology Therapy Product
 Table 111. Takeda Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 112. Takeda Recent Development
 Table 113. BioNTech SE Company Details
 Table 114. BioNTech SE Business Overview
 Table 115. BioNTech SE Immuno-oncology Therapy Product
 Table 116. BioNTech SE Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 117. BioNTech SE Recent Development
 Table 118. Allogene Therapeutics Company Details
 Table 119. Allogene Therapeutics Business Overview
 Table 120. Allogene Therapeutics Immuno-oncology Therapy Product
 Table 121. Allogene Therapeutics Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 122. Allogene Therapeutics Recent Development
 Table 123. IMAB-I-Mab Biopharma Co., Ltd. Company Details
 Table 124. IMAB-I-Mab Biopharma Co., Ltd. Business Overview
 Table 125. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product
 Table 126. IMAB-I-Mab Biopharma Co., Ltd. Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 127. IMAB-I-Mab Biopharma Co., Ltd. Recent Development
 Table 128. Arcus Biosciences Company Details
 Table 129. Arcus Biosciences Business Overview
 Table 130. Arcus Biosciences Immuno-oncology Therapy Product
 Table 131. Arcus Biosciences Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 132. Arcus Biosciences Recent Development
 Table 133. Gritstone Oncology Company Details
 Table 134. Gritstone Oncology Business Overview
 Table 135. Gritstone Oncology Immuno-oncology Therapy Product
 Table 136. Gritstone Oncology Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 137. Gritstone Oncology Recent Development
 Table 138. Autolus Therapeutics Company Details
 Table 139. Autolus Therapeutics Business Overview
 Table 140. Autolus Therapeutics Immuno-oncology Therapy Product
 Table 141. Autolus Therapeutics Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 142. Autolus Therapeutics Recent Development
 Table 143. Rubius Therapeutics Company Details
 Table 144. Rubius Therapeutics Business Overview
 Table 145. Rubius Therapeutics Immuno-oncology Therapy Product
 Table 146. Rubius Therapeutics Revenue in Immuno-oncology Therapy Business (2020-2025) & (US$ Million)
 Table 147. Rubius Therapeutics Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Immuno-oncology Therapy Picture
 Figure 2. Global Immuno-oncology Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Immuno-oncology Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Immune Checkpoint Inhibitors Features
 Figure 6. Immune System Modulators Features
 Figure 7. Cancer Vaccines Features
 Figure 8. Global Immuno-oncology Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Immuno-oncology Therapy Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Ambulatory Surgical Center Case Studies
 Figure 12. Others Case Studies
 Figure 13. Immuno-oncology Therapy Report Years Considered
 Figure 14. Global Immuno-oncology Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Immuno-oncology Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Immuno-oncology Therapy Market Share by Region: 2024 VS 2031
 Figure 17. Global Immuno-oncology Therapy Market Share by Players in 2024
 Figure 18. Global Top Immuno-oncology Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Immuno-oncology Therapy Revenue in 2024
 Figure 20. North America Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Immuno-oncology Therapy Market Share by Country (2020-2031)
 Figure 22. United States Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Immuno-oncology Therapy Market Share by Country (2020-2031)
 Figure 26. Germany Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Immuno-oncology Therapy Market Share by Region (2020-2031)
 Figure 34. China Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Immuno-oncology Therapy Market Share by Country (2020-2031)
 Figure 42. Mexico Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Immuno-oncology Therapy Market Share by Country (2020-2031)
 Figure 46. Turkey Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Immuno-oncology Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Amgen Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 50. AstraZeneca Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 52. Eli-Lilly Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 54. GlaxoSmithKline Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 55. Janssen Biotech Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 56. Merck Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 57. Novartis Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 58. Pfizer Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 59. Sanofi Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 60. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 61. Takeda Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 62. BioNTech SE Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 63. Allogene Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 64. IMAB-I-Mab Biopharma Co., Ltd. Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 65. Arcus Biosciences Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 66. Gritstone Oncology Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 67. Autolus Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 68. Rubius Therapeutics Revenue Growth Rate in Immuno-oncology Therapy Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Immuno Oncology Treatment Market Insights Forecast to 2030
Global Cancer Immunotherapy Market Insights Forecast to 2030
Global Immuno Oncology Service Market Research Report 2024
Global Immunocell Therapy Market Insights Forecast to 2030
Global Immunotherapeutic Drugs Market Insights Forecast to 2030
Global Immuno Cell Therapy Market Research Report 2024
Global Cancer Biotherapy Market Insights Forecast to 2030
Global Cancer Immunotherapies Market Insights Forecast to 2030
Global Cancer Immunosuppressant Treatment Market Research Report 2024
Global Cancer Immunotherapy Drugs Market Research Report 2024
Global Cancer Immuno Personalized Medicine Market Research Report 2024
Global Immuno oncology Clinical Trials Market Research Report 2024
Global Immunosuppressants in Cancer Therapy Market Research Report 2024
Global Immunotherapy Drugs Market Research Report 2024
Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adoptive Cell Therapy Market Insights Forecast to 2030
Global NK Cell Therapy Market Insights Forecast to 2030
Oncology Immunotherapy Market
Global Natural Killer Cell Therapy Market Insights Forecast to 2030
Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions